Citigroup’s Incannex Healthcare Limited Common Stock IXHL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.6K Buy
+2,814
New +$10.3K ﹤0.01% 5239
2025
Q4
– Sell
-5,924
Closed -$82.5K – 6257
2025
Q3
$82.5K Buy
5,924
+5,042
+572% +$81.9K ﹤0.01% 4332
2025
Q2
$5.71K Buy
+882
New +$8.72K ﹤0.01% 5261
2022
Q2
– Hold
0
– – – 6433
2022
Q1
– Hold
0
– – – 6474

Other funds holding IXHL

Citigroup's IXHL Position: Q2 2026 in Review

Citigroup opened a new position in Incannex Healthcare Limited Common Stock (IXHL) in Q2 2026: 2,814 shares worth $10.6K. The stake represents ﹤0.01% of the portfolio and ranks #5239 among its holdings. This is a return to the name: Citigroup previously reported a position in IXHL as recently as Q3 2025.

Citigroup first reported a position in IXHL in Q2 2025 and has held it in 3 quarters since. The position peaked at $82.5K in Q3 2025. 15 funds tracked by Wall St. Rank hold IXHL as of Q2 2026.

  • Citigroup held 2,814 shares of Incannex Healthcare Limited Common Stock worth $10.6K as of Q2 2026.
  • Incannex Healthcare Limited Common Stock was a new Citigroup position in Q2 2026.
  • Incannex Healthcare Limited Common Stock made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5239 holding.
  • Citigroup first reported a position in Incannex Healthcare Limited Common Stock in Q2 2025 and has held it in 3 quarters since.
  • Citigroup's Incannex Healthcare Limited Common Stock position peaked at $82.5K in Q3 2025.
  • 15 funds tracked by Wall St. Rank held Incannex Healthcare Limited Common Stock as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.